Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

The use of AlphaFold2-enabled molecular docking simulations to predict protein-ligand interactions for antibiotic drug discovery

Researchers demonstrated that advances in modeling protein-ligand interactions using machine learning-based approaches are needed to exploit AlphaFold2 for antibiotic discovery better.

9 Sep 2022

Research on the antimicrobial effects of human milk oligosaccharides

In a recent review published in the journal Current Opinion in Chemical Biology, researchers discussed the latest advances in the antimicrobial properties of human milk.

9 Sep 2022

Advances in modeling molecular interactions needed to better harness AlphaFold for drug discovery

Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming.

6 Sep 2022

Discovery of bacteria-killing toxin could pave the way for new generation of antibiotics

Researchers at McMaster University have discovered a previously unknown bacteria-killing toxin that could pave the way for a new generation of antibiotics.

6 Sep 2022

Novel method can be used to study the resistance profile of bacteria that cause meningitis

A study published in the journal PLOS ONE could one day help health workers determine whether bacteria of the species Streptococcus pneumoniae, which cause meningitis – an inflammation of the membranes that envelop the brain and spinal cord – are resistant to antibiotics.

6 Sep 2022

Naturally occurring compound possesses antibacterial activity against several microorganisms

University researchers have found a naturally occurring compound, known as hydroquinine, has bacterial killing activity against several microorganisms.

30 Aug 2022

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

According to the Centers for Disease Control and Prevention, more than 2.8 million Americans contract antibiotic-resistant bacterial infections each year, and approximately 35,000 of those patients do not survive their infection.

29 Aug 2022

What are the clinical characteristics and complications of patients with a monkeypox infection?

Researchers described the clinical characteristics and complications of monkeypox virus infections.

29 Aug 2022

Research receives NSF funding to fight against medical device infections

When Martha Grady tells her students about her research, she describes it as "shooting lasers at stuff to see what happens."

26 Aug 2022

Discovery may lead to the development of new systems of antifungal drugs

Mycosis is an infectious disease caused by parasitic mold or yeast and treated with an antifungal, a subgroup of antibiotics.

26 Aug 2022

Study shows how Klebsiella pneumoniae suppresses the body's defenses

New research published in Cell Reports has shown how the bacterium Klebsiella pneumoniae suppresses our body's defences, resulting in it being unable to clear infection.

24 Aug 2022

Case report on the post-orgasmic illness treated with antihistamines

Scientists discuss a post-orgasmic illness syndrome patient’s experience of being treated with an antihistamine.

23 Aug 2022

A practical guide for monkeypox diagnosis, prevention and treatment

Researchers provide an overview of the monkeypox infection in light of the current COVID-19 pandemic.

22 Aug 2022

What is the prevalence of bacterial co-infections during COVID-19?

Researchers evaluated the characteristics and prevalence of bacterial co-infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

22 Aug 2022

Mathematical model describes the simultaneous transmission of SARS-CoV-2 and multidrug-resistant bacteria

Researchers developed an epidemiological model to simulate the co-circulation of SARS-CoV-2 and multidrug-resistant bacteria in healthcare facilities during the early phase of the COVID-19 pandemic.

18 Aug 2022

Scientists elucidate the structure of Type IV secretion system involved in antibiotic resistance

With antibiotic-resistant bacteria on the rise, scientists have been searching for ways to shut down the Type IV secretion system (T4SS), a protein complex on the outer envelope of bacterial cells that helps them to exchange DNA with neighboring bacteria and resist antibiotics.

17 Aug 2022

Shelter sickness: Migrants see health problems linger and worsen while waiting at the border

Two days after arriving at a temporary migrant shelter at the border with the U.S. in June, Rosa Viridiana Ceron Alpizar's 9-year-old daughter and 1-year-old son fell ill. Most of the kids in the converted gym had stomach issues after being served a meal of sausage and beans, she recalled.

17 Aug 2022

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

A pioneering genomic surveillance study has provided the clearest picture yet of the arms race between Streptococcus pneumoniae, the bacterium responsible for a range of illnesses such as pneumonia and meningitis, and the vaccines designed to protect against the most dominant types. A strain called GPSC10 was found to be a particular threat, due to its increased virulence, ability to transform its structure to evade vaccines and its resistance to several common antibiotics.

17 Aug 2022

One Medicine: A collaboration for the benefit of both humans and animals

One Medicine is described as many different things by many different people. The UK charity that drives One Medicine – Humanimal Trust – defines it as collaboration between vets, doctors and researchers so that all humans and animals benefit from equitable and sustainable medical progress, but not at the expense of an animal’s life.

12 Aug 2022

How did the COVID-19 pandemic impact the epidemiology of antibiotic resistant bacteria?

In an article, a mathematical model was used to explore how behavioral responses to the COVID-19 pandemic impact the anti-microbial resistance across communities.

11 Aug 2022

Antibiotic News and Research

Further Reading

The use of AlphaFold2-enabled molecular docking simulations to predict protein-ligand interactions for antibiotic drug discovery

Research on the antimicrobial effects of human milk oligosaccharides

Advances in modeling molecular interactions needed to better harness AlphaFold for drug discovery

Discovery of bacteria-killing toxin could pave the way for new generation of antibiotics

Novel method can be used to study the resistance profile of bacteria that cause meningitis

Naturally occurring compound possesses antibacterial activity against several microorganisms

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

What are the clinical characteristics and complications of patients with a monkeypox infection?

Research receives NSF funding to fight against medical device infections

Discovery may lead to the development of new systems of antifungal drugs

Study shows how Klebsiella pneumoniae suppresses the body's defenses

Case report on the post-orgasmic illness treated with antihistamines

A practical guide for monkeypox diagnosis, prevention and treatment

What is the prevalence of bacterial co-infections during COVID-19?

Mathematical model describes the simultaneous transmission of SARS-CoV-2 and multidrug-resistant bacteria

Scientists elucidate the structure of Type IV secretion system involved in antibiotic resistance

Shelter sickness: Migrants see health problems linger and worsen while waiting at the border

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

One Medicine: A collaboration for the benefit of both humans and animals

How did the COVID-19 pandemic impact the epidemiology of antibiotic resistant bacteria?

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News